MiniMed gets FDA clearance for MiniMed Flex, its smallest smartphone-controlled insulin pump
Source: SeekingAlpha
2026-03-18 09:16:45 ET
More on MiniMed Group, Inc.
- MiniMed Group: Medtronic's Diabetes Business Does Not Convince
- MiniMed Group Files For IPO In Medtronic Carve-Out
- Medtronic’s diabetes unit MiniMed drops on trading debut
- Medtronic subsidiary MiniMed prices $560M IPO at $20 per share
- Financial information for MiniMed Group, Inc.
Read the full article on Seeking Alpha
For further details see:
MiniMed gets FDA clearance for MiniMed Flex, its smallest smartphone-controlled insulin pump
MiniMed Group Inc.
NASDAQ: MMED
MMED Trading
17.32% G/L:
$14.29 Last:
1,637,892 Volume:
$12.72 Open:
MMED Latest News
June 03, 2026 06:47:00 am
MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott
